Glassman Wealth Services Innoviva, Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.32 - $16.27 $221 - $292	18 New	18 $0
Q3 2022 Nov 09, 2022	SELL	$11.61 - $15.22 $92 - $121	-8 Reduced 38.1%	13 $0
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $274 - $362	21 New	21 $0
Q3 2019 Nov 01, 2019	SELL	$10.05 - $14.55 $251 - $363	-25 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$13.1 - $14.95 $327 - $373	25 New	25 $0

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.